Survival curves for all-cause and cardiovascular mortality.

(A) All-cause mortality according to AAC progression. (B) Cardiovascular mortality according to AAC progression. (C) All-cause mortality according to baseline AAC. (D) Cardiovascular mortality according to baseline AAC. The 7.5-year overall survival was significantly lower in patients with AAC progression (45.3% vs. 79.5%) as well as baseline AAC (53.8% vs. 75.0%) than in those without.